Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

18.30USD
22 Mar 2019
Change (% chg)

$-1.34 (-6.82%)
Prev Close
$19.64
Open
$19.49
Day's High
$19.50
Day's Low
$18.27
Volume
179,015
Avg. Vol
204,058
52-wk High
$24.30
52-wk Low
$11.48

Chart for

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 3.11
Market Cap(Mil.): $444.74
Shares Outstanding(Mil.): 32.58
Dividend: --
Yield (%): --

Financials

  CARA.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -2.33 -- --
ROI: -66.80 8.89 13.82
ROE: -67.79 10.02 15.24

Earnings vs. Estimates